Winning the new shape of demand will require targeting and appealing to each segment differently, rather than treating GLP-1 users as a single, homogeneous consumer group, says Lauren Taylor, a BCG managing director and senior partner who leads CCI globally
Literature [1] Brass, E.P
Experts also point out that there have been no placebo-controlled clinical studies in this population to date and more quality research is needed
Jill Carnahan for a powerful, research-informed, and deeply compassionate conversation exploring the intricate link between Mast Cell Activation Syndrome (MCAS) , systemic inflammation, and the emerging role of GLP-1 medications and natural alternatives
What influences GLP-1 results Average weight loss results for GLP-1 medications are shaped by many different factors, including: Starting weight How quickly you go up in doses How long you stay on treatment Side-effect tolerance Health conditions Other medications being taken Supportive habits such as nutrition, adequate protein intake, exercise, quality sleep, and stress management As weight loss results and side effects can vary, all decisions regarding dose adjustments or symptoms should be made with a qualified clinician